Last updated: May 8, 2024
Sponsor: Icahn School of Medicine at Mount Sinai
Overall Status: Active - Recruiting
Phase
N/A
Condition
Asperger's Disorder
Sjögren-larsson Syndrome
Learning Disorders
Treatment
N/AClinical Study ID
NCT03718910
GCO 98-436 - B
Ages > 2 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Eligible participants must have a documented variant affecting the DDX3X gene that theresearch team determines to be likely or definitely pathogenic.
- Eligible participants must be at least 2 years of age.
Exclusion
Exclusion Criteria:
- None
Study Design
Total Participants: 10
Study Start date:
May 22, 2018
Estimated Completion Date:
May 31, 2026
Study Description
Connect with a study center
The Seaver Autism Center for Research and Treatment
New York, New York 10029
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.